Literature DB >> 23123734

Estrogen-related receptor α in normal adrenal cortex and adrenocortical tumors: involvement in development and oncogenesis.

Saulo J A Felizola1, Yasuhiro Nakamura, Xiao-Gang Hui, Fumitoshi Satoh, Ryo Morimoto, Keely M McNamara, Sanae Midorikawa, Shinichi Suzuki, William E Rainey, Hironobu Sasano.   

Abstract

AIMS: The nuclear hormone receptor estrogen-related receptor α (ERRα) regulates the activation of mitochondrial genes in various human tissues, but its role in the adrenal gland and its disorders has not been defined. Therefore, we examined ERRα expression in both normal adrenal cortex (NAC) and adrenocortical tumor (ACT) in order to study the possible correlation of ERRα with adrenal development and tumor development.
METHODS: Human adrenal specimens (non-pathological fetal n=7; non-pathological post-birth n=40; aldosterone producing adenoma (APA) n=11; cortisol producing adenoma (CPA) n=11; adrenocortical carcinoma (ACC) n=8) were immunohistochemically examined in this study. NAC (n=13) and ACT (n=28) frozen tissue specimens were also available for studying ERRα mRNA levels. KEY
FINDINGS: In fetal NAC tissues, ERRα labeling index (LI) in fetal zone (FZ) was significantly higher that that in neocortex (NC), and the differences among age groups for overall mean LI was statistically significant when analyzed according to individual cortical layers. ERRα LI was also significantly higher in ACC than in other types of ACT. ERRα mRNA was detected in NAC and all types of ACT. SIGNIFICANCE: Results of our present study suggest a possible role of ERRα in adrenal development and ACC.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123734      PMCID: PMC4097865          DOI: 10.1016/j.mce.2012.10.020

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  42 in total

Review 1.  Premature adrenarche.

Authors:  Rachel M Williams; Caleb E Ward; Ieuan A Hughes
Journal:  Arch Dis Child       Date:  2011-08-11       Impact factor: 3.791

2.  The nuclear receptor superfamily: a personal retrospect on the first two decades.

Authors:  Pierre Chambon
Journal:  Mol Endocrinol       Date:  2005-06

Review 3.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

Authors:  R M Sapolsky; L C Krey; B S McEwen
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

4.  Transcriptional regulation of dehydroepiandrosterone sulfotransferase (SULT2A1) by estrogen-related receptor alpha.

Authors:  Jeremiah Seely; Karla Saner Amigh; Takashi Suzuki; Bobbie Mayhew; Hironobu Sasano; Vincent Giguere; Josée Laganière; Bruce R Carr; William E Rainey
Journal:  Endocrinology       Date:  2005-05-05       Impact factor: 4.736

Review 5.  Dissecting human adrenal androgen production.

Authors:  William E Rainey; Bruce R Carr; Hironobu Sasano; Takashi Suzuki; J Ian Mason
Journal:  Trends Endocrinol Metab       Date:  2002-08       Impact factor: 12.015

6.  Estrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts.

Authors:  Michael J Chisamore; Hilary A Wilkinson; Osvaldo Flores; J Don Chen
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

7.  Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Norihiro Shimada; Takanori Ishida; Hisashi Hirakawa; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

8.  Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers.

Authors:  Jiro Fujimoto; Eriko Sato
Journal:  J Steroid Biochem Mol Biol       Date:  2009-05-03       Impact factor: 4.292

Review 9.  Premature adrenarche: novel lessons from early onset androgen excess.

Authors:  Jan Idkowiak; Gareth G Lavery; Vivek Dhir; Timothy G Barrett; Paul M Stewart; Nils Krone; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2011-05-26       Impact factor: 6.664

Review 10.  The critical role of metabolic pathways in aging.

Authors:  Nir Barzilai; Derek M Huffman; Radhika H Muzumdar; Andrzej Bartke
Journal:  Diabetes       Date:  2012-06       Impact factor: 9.461

View more
  8 in total

1.  PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues.

Authors:  Saulo J A Felizola; Yasuhiro Nakamura; Yoshikiyo Ono; Kanako Kitamura; Kumi Kikuchi; Yoshiaki Onodera; Kazue Ise; Kei Takase; Akira Sugawara; Namita Hattangady; William E Rainey; Fumitoshi Satoh; Hironobu Sasano
Journal:  J Mol Endocrinol       Date:  2014-02-24       Impact factor: 5.098

2.  3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma.

Authors:  Sachiko Konosu-Fukaya; Yasuhiro Nakamura; Fumitoshi Satoh; Saulo J A Felizola; Takashi Maekawa; Yoshikiyo Ono; Ryo Morimoto; Kazue Ise; Ken-Ichiro Takeda; Koshin Katsu; Fumiyoshi Fujishima; Atsuko Kasajima; Mika Watanabe; Yoichi Arai; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Masao Doi; Hitoshi Okamura; Hironobu Sasano
Journal:  Mol Cell Endocrinol       Date:  2014-10-22       Impact factor: 4.102

3.  Metallothionein-3 (MT-3) in the human adrenal cortex and its disorders.

Authors:  Saulo J A Felizola; Yasuhiro Nakamura; Yuki Arata; Kazue Ise; Fumitoshi Satoh; William E Rainey; Sanae Midorikawa; Shinichi Suzuki; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

4.  Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC).

Authors:  Ivan Casaburi; Paola Avena; Arianna De Luca; Adele Chimento; Rosa Sirianni; Rocco Malivindi; Vittoria Rago; Marco Fiorillo; Francesco Domanico; Carmela Campana; Anna Rita Cappello; Federica Sotgia; Michael P Lisanti; Vincenzo Pezzi
Journal:  Oncotarget       Date:  2015-09-22

Review 5.  Modulation of Autophagy in Adrenal Tumors.

Authors:  Diana Sousa; Sofia S Pereira; Duarte Pignatelli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

6.  Prognostic Factors for Adrenocortical Carcinoma Outcomes.

Authors:  Claudia Scollo; Marco Russo; Maria Antonietta Trovato; Daniela Sambataro; Dario Giuffrida; Mario Manusia; Giulia Sapuppo; Pasqualino Malandrino; Riccardo Vigneri; Gabriella Pellegriti
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-25       Impact factor: 5.555

Review 7.  Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment.

Authors:  Ivan Casaburi; Adele Chimento; Arianna De Luca; Marta Nocito; Sara Sculco; Paola Avena; Francesca Trotta; Vittoria Rago; Rosa Sirianni; Vincenzo Pezzi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-11       Impact factor: 5.555

8.  Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma.

Authors:  Sarah Allegra; Soraya Puglisi; Irene Brescia; Francesco Chiara; Vittoria Basile; Anna Calabrese; Giuseppe Reimondo; Silvia De Francia
Journal:  Life (Basel)       Date:  2021-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.